NewsAvi Kapoor
MDxHealth SA
MDXH · NASDAQ
$0.1833−$0.0007 (−0.38%)TodayMarket closed ·
Prev close $0.184
Latest news
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- NewsAvi Kapoor
Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings
- NewsAvi Kapoor
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
- NewsVandana Singh
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA'
- Press releaseGlobe Newswire
These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- NewsAvi Kapoor
Dow Falls Over 100 Points; US Consumer Sentiment Declines In August
- NewsAvi Kapoor
US Stocks Mixed; Retail Sales Fall In July
- News
Full Transcript: MDxHealth Q2 2026 Earnings Call
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseGlobe Newswire
Mdxhealth Reports Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Dow Jumps Over 250 Points; US Retail Sales Increase In April
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Mdxhealth Reports Q1-2026 Results
- Press releaseGlobe Newswire
Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
- Press releaseGlobe Newswire
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results
- Press releaseGlobe Newswire
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
- Press releaseGlobe Newswire
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
- Press releaseGlobe Newswire
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
- Press releaseACCESS Newswire
Angle PLC Announces Strategy Update
- News
Insights Ahead: MDxHealth's Quarterly Earnings
- NewsAvi Kapoor
Dow Surges Over 250 Points; Accenture Earnings Top Views
- NewsAvi Kapoor
Crude Oil Down Over 2%; US Initial Jobless Claims Fall
- NewsAvi Kapoor
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
MDxHealth Announces Pricing of Offering of Ordinary Shares
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.